LBA1 Denosumab added to 2 different nab-paclitaxel regimens as neoadjuvant therapy in patients with primary breast cancer: Time to event analysis from the GeparX 2 × 2 randomized c... by Loibl, S., Reinisch, M., Just, M., Untch, M., Stoetzer, O.J., Schneeweiss, A., Fasching, P.A., Wimberger, P., Seiler, S., Huober, J., Thill, M., Rhiem, K.E., Solbach, C., Hanusch, C., Denkert, C., Engels, K., Filmann, N., Holtschmidt, J., Blohmer, J-U., Link, T.

Get full text